Vaccine 1st puts spotlight on German pharma company BioNTech
MAINZ, Germany (AP) — The email that arrived in the ancient German city of Mainz shortly before 1 a.m. in the morning marked a turning point in the global effort to deliver a reliable vaccine against the coronavirus pandemic - and for the little-known biotechnology company that helped develop it.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
